Victory Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $109K | Buy |
30,032
+4,768
| +19% | +$17.4K | ﹤0.01% | 2318 |
|
2025
Q1 | $48.5K | Sell |
25,264
-417
| -2% | -$801 | ﹤0.01% | 2367 |
|
2024
Q4 | $48.8K | Buy |
25,681
+336
| +1% | +$638 | ﹤0.01% | 2399 |
|
2024
Q3 | $33.5K | Buy |
25,345
+518
| +2% | +$684 | ﹤0.01% | 2419 |
|
2024
Q2 | $25.3K | Buy |
24,827
+3,010
| +14% | +$3.07K | ﹤0.01% | 2412 |
|
2024
Q1 | $39.9K | Sell |
21,817
-702
| -3% | -$1.29K | ﹤0.01% | 2393 |
|
2023
Q4 | $27.9K | Sell |
22,519
-732,969
| -97% | -$909K | ﹤0.01% | 2485 |
|
2023
Q3 | $861K | Buy |
755,488
+93,590
| +14% | +$107K | ﹤0.01% | 1732 |
|
2023
Q2 | $606K | Buy |
661,898
+404,154
| +157% | +$370K | ﹤0.01% | 1902 |
|
2023
Q1 | $144K | Buy |
257,744
+237,922
| +1,200% | +$133K | ﹤0.01% | 2306 |
|
2022
Q4 | $11.4K | Sell |
19,822
-8
| -0% | -$5 | ﹤0.01% | 2539 |
|
2022
Q3 | $6K | Sell |
19,830
-4,148
| -17% | -$1.26K | ﹤0.01% | 2675 |
|
2022
Q2 | $8K | Buy |
23,978
+965
| +4% | +$322 | ﹤0.01% | 2663 |
|
2022
Q1 | $10K | Sell |
23,013
-657
| -3% | -$285 | ﹤0.01% | 2679 |
|
2021
Q4 | $53K | Sell |
23,670
-677
| -3% | -$1.52K | ﹤0.01% | 2636 |
|
2021
Q3 | $70K | Buy |
24,347
+883
| +4% | +$2.54K | ﹤0.01% | 2658 |
|
2021
Q2 | $89K | Buy |
23,464
+276
| +1% | +$1.05K | ﹤0.01% | 2611 |
|
2021
Q1 | $78K | Buy |
23,188
+669
| +3% | +$2.25K | ﹤0.01% | 2627 |
|
2020
Q4 | $63K | Buy |
22,519
+1,330
| +6% | +$3.72K | ﹤0.01% | 2446 |
|
2020
Q3 | $53K | Sell |
21,189
-1,138
| -5% | -$2.85K | ﹤0.01% | 2385 |
|
2020
Q2 | $303K | Sell |
22,327
-15,585
| -41% | -$212K | ﹤0.01% | 2171 |
|
2020
Q1 | $288K | Buy |
37,912
+7,801
| +26% | +$59.3K | ﹤0.01% | 2243 |
|
2019
Q4 | $190K | Buy |
30,111
+10,163
| +51% | +$64.1K | ﹤0.01% | 2322 |
|
2019
Q3 | $78K | Buy |
+19,948
| New | +$78K | ﹤0.01% | 2518 |
|